You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. The advent of nanotechnology has ushered in a transformative era for oncology, offering unprecedented capabilities for targeted drug delivery and controlled release. This paradigm shift enhances therapeutic efficacy while mitigating the debilitating side
- 2. The role of cytostatic in oxidative stress reactions
- 3. Trinity Capital Inc. Provides $130 Million in Growth Capital to Candel Therapeutics, Supporting Development of Viral Immunotherapies to Fight Cancer
- 4. Actinium to Present ATNM-400 Preclinical Data Highlighting Durable Tumor Control and Ability to Overcome Resistance to Standard-of-Care Prostate Cancer Therapies at the 32nd Annual Prostate Cancer Foundation Scientific Retreat
- 5. 9Prostate cancer screening urgently needed, says Rishi Sunak
- 6. Multimodal integration of [18F]PSMA-1007 PET/CT semiquantitative parameters and clinicopathological data for predicting prostate cancer metastasis
- 7. Curium Group, PeptiDream and PDRadiopharma Enroll First Patient to Registrational Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan
- 8. Effects of Dexmedetomidine Nasal Sprays on Postoperative Sleep Quality in Patients Who Underwent Laparoscopic Gynaecological Surgery: A Single-Centre, Double-Blind, Randomized Controlled Study
- 9. Rosai-Dorfman disease mimicking lung cancer: a case report
- 10. Case Report: Trametinib in the treatment of patients with metastatic lung adenocarcinoma harboring NF1 mutation: a case series and literature review
Last updated at 21:58 GMT
Hot News Makers
Health/Pharma Companies
-
36794.57
-
14413.33
-
11882.74
-
11700.06
-
11330.32
-
9711.70
-
8358.75
-
7867.06
-
7384.42
-
6650.05
Drugs, Treatments, Trials
-
13020.30
-
8729.33
-
8332.55
-
7079.99
-
5813.77
-
5347.83
-
4629.23
-
4093.04
-
2777.65
-
2183.11
Last updated at 21:10 GMT
